TrialThe New England journal of medicine2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
Dean F Bajorin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
534 papers cite itlatest 60 shown
this paperpooled ittrialcites it